Brain bleed breakthrough? massive study tests surgery vs. standard care

NCT ID NCT05975398

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This large registry study tracks 2,000 adults in China with severe spontaneous brain hemorrhage to compare outcomes of emergency surgery versus conservative (non-surgical) treatment. It focuses on patients who take long-term antiplatelet drugs (like aspirin) to see if surgery is safe and effective for them. Researchers also monitor complications like bleeding after surgery and disorders of consciousness. The goal is to generate real-world evidence to guide treatment decisions for this life-threatening condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could clarify whether emergency surgery saves more lives than standard care for severe brain bleeds, particularly in patients on blood thinners.
What could go wrong
This is an observational registry, not a controlled experiment, so results may show associations but not prove cause and effect. Findings may not apply outside China.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Consciousness Disorders intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Capital Medical University Affiliated Beijing Tiantan Hospital

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.